{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-22-000044","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.851315+00:00","generated_at":"2026-06-22T06:16:14.227658+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ICU Medical Q3 2022 revenue $597.9M; GAAP loss $(0.55)/share; adj EPS $1.75","bullets":["Revenue $597.9M vs $336.1M YoY (+78%); GAAP net loss $(13.2)M ($(0.55)/diluted share).","Adjusted diluted EPS $1.75 vs $2.07 YoY; adjusted EBITDA $92.6M vs $71.9M.","GAAP gross margin 31% vs 38% YoY; gross profit $186.4M vs $127.8M.","Reaffirmed fiscal year 2022 guidance; no specific guidance numbers provided."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-22-000044","json":"https://secwatch.observer/filing/0000883984-22-000044.json","markdown":"https://secwatch.observer/filing/0000883984-22-000044.md","text":"https://secwatch.observer/filing/0000883984-22-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/icui-20221107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T06:16:14.227658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"294d39a1d15e64e72e87be63ffd5bbc8b686e14c","claim":"ICU MEDICAL INC/DE reported For the quarter ended September 30, 2022 results: revenue Third quarter 2022 revenue was $597.9 million, net income GAAP net loss for the third quarter of 2022 was $(13.2) million, EPS Adjusted diluted earnings per share for the third quarter of 2022 was $1.75. Guidance reaffirmed.","evidence_excerpt":"ICU Medical Announces Third Quarter 2022 Results The Company Reaffirms 2022 Fiscal Year Guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"For the quarter ended September 30, 2022"},{"label":"Revenue","value":"Third quarter 2022 revenue was $597.9 million"},{"label":"Net income","value":"GAAP net loss for the third quarter of 2022 was $(13.2) million"},{"label":"EPS","value":"Adjusted diluted earnings per share for the third quarter of 2022 was $1.75"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}